Sutro Biopharma STRO
NASDAQ STRO
$15.35 -0.62 (-3.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Return on Equity [ROE] (2019 - 2025)

Updated

Sutro Biopharma (STRO) recorded Return on Equity [ROE] of -2497.18% in Q1 2025, down 2404.34 percentage points from -92.84% a year earlier and down 2205.18 percentage points from the prior quarter.

Analysis

Sutro Biopharma (STRO) Return on Equity [ROE] (2019 - 2025) Analysis & Trends

For FY2024, Sutro Biopharma reported Return on Equity [ROE] of -234.23%, down 175.98 percentage points from FY2023.

  • Annual Return on Equity [ROE] has declined for four straight years, with a five-year change of -185.62 percentage points (FY2019 to FY2024).
  • Across earlier years, Return on Equity [ROE] came in at -58.25% in FY2023 (-7.48 pp), -50.77% in FY2022 (-14.66 pp), -36.11% in FY2021 (-21.16 pp) and -14.95% in FY2020 (+33.67 pp).
  • The Q1 2025 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q1 2019.
  • On a year-over-year basis, Return on Equity [ROE] rose in 1 of the last eight quarters, with an average year-over-year change of -343.29 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 43.16 percentage points in Q1 2021, against a drop of 2404.34 percentage points in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -292.00% (Q4 2024), -94.13% (Q3 2024) and -99.49% (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Sutro Biopharma 254.44 Mn -424.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -2,497.18%
Dec 31, 2024 -292.00%
Sep 30, 2024 -94.13%
Jun 30, 2024 -99.49%
Mar 31, 2024 -92.84%
Dec 31, 2023 -81.50%
Sep 30, 2023 -129.11%
Jun 30, 2023 -83.88%
Mar 31, 2023 -64.67%
Dec 31, 2022 -53.36%
Sep 30, 2022 -55.94%
Jun 30, 2022 -62.48%
Mar 31, 2022 -48.33%
Dec 31, 2021 -35.38%
Sep 30, 2021 -28.63%
Jun 30, 2021 -21.58%
Mar 31, 2021 -24.77%
Dec 31, 2020 -27.46%
Sep 30, 2020 -29.28%
Jun 30, 2020 -45.90%
API Access

Sutro Biopharma Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=STRO&period=max&api_key=YOUR_API_KEY